Fiche publication
Date publication
décembre 2011
Lien Pubmed
Résumé
Treatment with biologics requires specific evaluation based on assessment of clinical efficacy, of comorbidities and of safety. Although evaluation is mainly clinical, additional laboratory investigations may be needed. The occurrence of events, whether disease-related (infection, dysimmunity, cancer) or not (pregnancy, vaccination), is described in specific guidelines and in notification reports submitted to pharmacovigilance agencies.
Référence
Ann Dermatol Venereol. 2011 Dec;138(12):851-3
